Rafael Pieretti-Vanmarcke
Pediatric Surgical Research Laboratories
Department of Surgery
Massachusetts General Hospital
Boston
USA
Name/email consistency: high
- Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo. Pieretti-Vanmarcke, R., Donahoe, P.K., Szotek, P., Manganaro, T., Lorenzen, M.K., Lorenzen, J., Connolly, D.C., Halpern, E.F., MacLaughlin, D.T. Clin. Cancer Res. (2006)